Rapafusyn Pharmaceuticals Raises $28 Million to Revolutionize Drug Discovery with Innovative Molecular Glue Platform

Rapafusyn Pharmaceuticals, a trailblazer in the realm of therapeutic drug discovery, has announced a significant milestone with the closure of a Series A financing round, amassing $28 million. This strategic investment round was led by 3E Bioventures Capital and Proxima Ventures Ltd., with participation from Lapam Capital. Rapafusyn is spearheading the development of non-degrading molecular…

Read More

Cellino Secures $25 Million Grant from ARPA-H to Revolutionize Biomanufacturing for Personalized Regenerative Medicine

In a landmark development for the field of regenerative medicine, Cellino Biotech, Inc. has been awarded up to $25 million in funding from the Advanced Research Projects Agency for Health (ARPA-H), a division within the U.S. Department of Health and Human Services. This grant will significantly advance Cellino’s NEBULA, a cutting-edge biomanufacturing technology designed to…

Read More

Redaptive Secures $100 Million Investment to Propel Global Decarbonization Efforts

Redaptive, a trailblazer in the Energy-as-a-Service (EaaS) sector, has announced a significant $100 million equity investment from the Canada Pension Plan Investment Board (CPP Investments). This strategic funding is set to accelerate Redaptive’s expansion, enhance its service offerings, and support a burgeoning clientele in their pursuit of net-zero emissions goals. The urgency for decarbonization has…

Read More
Vizzu

Vizzu Secures $1.5M Funding to Revolutionize Data Storytelling

Data storytelling innovator Vizzu has announced a significant milestone with the successful raise of $1.5 million in funding, marking a pivotal moment in their journey towards transforming how data is visualized and communicated. This funding round, supported by the Interactive Venture Partners Fund and prominent investor Thomas Peterffy’s family office, along with Two Sigma, underscores…

Read More

Helpt Secures $850,000 Seed Funding to Expand Technical Support Solutions

Helpt, a U.S.-based leader in technical and customer service solutions, has successfully raised $850,000 in seed funding from Dealbrook Holdings II. This significant investment will accelerate Helpt’s growth by expanding its service offerings, advancing platform development, and enhancing its sales and marketing efforts. Founded in 2022 by Matthew Pincus and David Sohn, Helpt delivers a…

Read More

Quantiphi Honored with AIFinTech100 Recognition for Fourth Consecutive Year

Quantiphi, a pioneering AI-first digital engineering firm, has once again secured its position among the elite in financial technology innovation with its fourth consecutive recognition by AIFinTech100. This prestigious accolade acknowledges Quantiphi’s steadfast commitment to revolutionizing the financial services landscape through cutting-edge AI technologies. AIFinTech100, renowned for its meticulous selection process led by industry experts…

Read More

Beacon Therapeutics Raises $170 Million to Propel Ophthalmic Gene Therapy Innovations

Beacon Therapeutics, a pioneering ophthalmic gene therapy company dedicated to combating blinding retinal diseases, has secured $170 million in Series B funding, marking a significant stride towards advancing its transformative treatments. Led by Forbion and supported by existing investors Syncona and Oxford Science Enterprises, alongside newcomers TCGX and Advent Life Sciences, this funding round will…

Read More

AeroShield Materials Unveils New Waltham Facility and Secures $5 Million in Funding for Revolutionary Energy-Efficient Technologies

AeroShield Materials, a pioneering MIT spin-out at the forefront of energy-efficient technology, proudly announced the grand opening of its state-of-the-art manufacturing facility in Waltham, Massachusetts. The company has also secured an additional $5 million in funding, supported by both existing and new investors including Massachusetts Clean Energy Center (MassCEC), MassVentures, and MassMutual Ventures. The new…

Read More

RevOpsis Appoints Ronil Patel as Chief Business Officer

RevOpsis Therapeutics, a pioneering biopharmaceutical firm at the forefront of developing advanced ophthalmic therapies, has named Ronil Patel as its new Chief Business Officer. Patel brings over 15 years of extensive experience in biotechnology and global business development to his role, effective immediately. In his new capacity, Patel will steer RevOpsis’ global strategy and spearhead…

Read More

ConfidentialMind Secures €1.5 Million to Pave the Way for On-Premises Generative AI

In a significant stride towards advancing enterprise and government applications of generative AI, Espoo-based startup ConfidentialMind has raised €1.5 million in a pre-seed funding round. This investment, spearheaded by Failup Ventures and complemented by participation from Angel CoFund and notable angel investors, marks a pivotal moment for the company founded just a year ago. Founded…

Read More